Clinical trial NCT00755690: Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease
Official title: Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Kidney Diseases
Keywords: Chronic Kidney Disease
CKD
Diet
Dietary Phosphate
Mineral Metabolism
FGF-23
Lead sponsor: University of British Columbia
Sponsor class: OTHER
First posted: 2008-09-19
Enrollment: 32
Sex: ALL
Minimum age (years): 19
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: TREATMENT

Brief summary: This study is designed to describe the physiological response to increased and decreased dietary phosphate intake on various parameters of mineral metabolism in the blood and urine of individuals with Chronic Kidney Disease stage 3 and 4 with normal serum phosphate levels. This detailed study will give us a far greater understanding of the role of diet in abnormal mineral homeostasis early in the progression of this chronic disease. The findings of this study will help both physicians and dietitians better determine the optimal time to introduce dietary therapy in CKD.

Detailed description: The potential benefits of implementation of phosphate management earlier in CKD (Stages 3/4) are threefold: 1) prevention of vascular damage early in the progression of CKD thus reducing risk of cardiovascular death 2) Improved management of renal bone disease and resultant co-morbidities and 3) slowing the progression of renal failure lengthening the time required till dialysis is required. Although dietary counseling is currently a normal part of CKD care, the utility and effectiveness of lowering phosphate has not previously been quantified. In part this is due to the difficulty of measurement of serum phosphate as it is so tightly controlled before GFR falls below 30mls/min. No studies have investigated whether is it possible to modulate circulating FGF-23 and phosphate excretion in early stages of renal failure using diet in individuals with normal serum phosphate levels.

Study Objectives ;

1. To measure FGF-23 levels before and after a high phosphate diet, low phosphate diet and a low phosphate diet with phosphate binders.
2. To measure levels of calcium, phosphate, PTH, 25 and 1,25 vitamin D and fractional phosphate excretion before and after a high phosphate diet, low phosphate diet and a low phosphate diet with phosphate binders.

Eligibility criteria: Inclusion Criteria:

* CKD patients with CKD stage 3 and 4 (eGFR \< 60 ml/min and \> 15 ml/min per 1.73 m2, not requiring dialysis).
* Normal serum phosphate stable over three months (\> 0.87 mmol/L and \< 1.70 mmol/L)
* Not yet following a low phosphate diet as reported by the patient or the renal dietitian (\<1500mg/d)
* Over 19 years of age

Exclusion Criteria:

* Body mass index \<20 kg/m2
* Current use of phosphate binders or active vitamin D or phenytonin (which induces vitamin D catabolism)
* Primary parathyroid defects
* Diagnosed osteoporosis
* Gut absorption defects
* Liver disease
* Pregnancy or lactation
* Patients hospitalised within the last 4 weeks

Primary outcomes:
measure: FGF-23
timeFrame: 5 days
Secondary outcomes:
measure: Serum calcium, phosphate, PTH, 25 and 1,25 vitamin D and fractional phosphate excretion.
timeFrame: 5 days
Other outcomes:
Locations:
city: Vancouver
country: Canada
facility: St. Paul's Hospital
state: British Columbia
Study officials:
affiliation: University of British Columbia
name: Adeera Levin, MD
role: PRINCIPAL_INVESTIGATOR
References: